Prescribing an oral contraceptive for the individual woman
Chick, P.
Australian Family Physician Suppl: 8-12
1980
ISSN/ISBN: 0300-8495 PMID: 6444808 Document Number: 451841
It is possible to find a formulation suitable to almost any woman requesting oral contraception. Low dosage and strong affinity for target cell receptors are important in the selection of the appropriate agent. Details are given of an extensive clinical trial of a biphasic formulation containing ethinyloestradiol and levonorgestrel.
Document emailed within 1 workday
Related Documents
van Lunsen, H.W. 1996: Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 1(1): 39-45van Lunsen, H.W. 1996: Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 1(1): 39-45
Sulak, P.J. 1991: The career woman and oral contraceptive use International Journal of Fertility 36(Suppl 2): 90
Mateos Lindemann, M.L.; Morales, J.G.; Fernández-Barredo, S.; Domínguez, M.R.íg.; García de la Hoz, F.; Halfon, P.; Pérez Gracia, M.T. 2010: Fulminant hepatitis e in a woman taking oral contraceptive medication American Journal of Tropical Medicine and Hygiene 82(1): 12-15
Cheah, J.S. 1972: Deep thrombophlebitis of the leg in a Chinese woman on oral contraceptive pill Singapore Medical Journal 13(3): 166-167
Meyers, A.B.; Rhodes, J.E. 1995: Oral contraceptive use among African American adolescents: individual and community influences American Journal of Community Psychology 23(1): 99-115
Seon, C.S.; Park, Y.S.; Park, S.H.; Ryu, S.R.; Jo, Y.J.; Kim, S.H.; Son, B.K.; Ahn, S.B. 2011: A Case of Oral-contraceptive Related Ischemic Colitis in Young Woman Clinical Endoscopy 44(2): 129-132
Piparva, K.G.; Buch, J.G. 2011: Deep vein thrombosis in a woman taking oral combined contraceptive pills Journal of Pharmacology and Pharmacotherapeutics 2(3): 185-186
Girolami, A.; Vettore, S.; Tezza, F.; Girolami, B. 2007: Retinal central artery occlusion in a young woman after ten days of a drospirenone-containing oral contraceptive (Yasmin) Thrombosis and Haemostasis 98(2): 473-474
Szlendak-Sauer, K.; Radowicki, S.ła.; Skórzewska, K. 2009: The influence of a combined low dose oral contraceptive containing drospirenone on electrolite equlibrum and renal function in young woman Ginekologia Polska 80(1): 33-37
Wharton, H.C. 2012: A 21-year-old white woman diagnosed with cerebral venous sinus thrombosis related to oral contraceptive and Factor V Leiden Advanced Emergency Nursing Journal 34(1): 10-15
Rushton, L.; Jones, D.R. 1992: Oral contraceptive use and breast cancer risk: a meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use British Journal of Obstetrics and Gynaecology 99(3): 239-246
Kaul, L.; Ahluwalia, B. 1978: Interrelation of caffeine and oral contraceptive steroid metabolism in hypertensive oral contraceptive users in humans Journal of Steroid Biochemistry 9(9): 862-863
Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469
Samy Suissa; Brenda Hemmelgarn; Walter, O. Spitzer; James Brophy; Jean-Paul Collet; Robert Cǒte; Winanne Downey; Lindsay Edouard; Jacques Leclerc; Ora Paltiel 1993: The Saskatchewan oral contraceptive cohort study of oral contraceptive use and cardiovascular risks Pharmacoepidemiology and Drug Safety 2(1): 33-49
Paleev, N.R.; Kaevitser, I.M.; Kublanov, L.A. 1977: Determination of the individual changes in cardiovascular system reactivity in prescribing adrenergic blockaders Kardiologiia 17(11): 103-108
Gingnell, M.; Engman, J.; Frick, A.; Moby, L.; Wikström, J.; Fredrikson, M.; Sundström-Poromaa, I. 2013: Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill--a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive Psychoneuroendocrinology 38(7): 1133-1144
Audet, M.C.; Moreau, M.; Koltun, W.D.; Waldbaum, A.S.; Shangold, G.; Fisher, A.C.; Creasy, G.W. 2001: Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial JAMA 285(18): 2347-2354
Lee, H.; Petrofsky, J.S.; Daher, N.; Berk, L.; Laymon, M. 2014: Differences in anterior cruciate ligament elasticity and force for knee flexion in women: oral contraceptive users versus non-oral contraceptive users European Journal of Applied Physiology 114(2): 285-294
Lee, H.; Petrofsky, J.S.; Daher, N.; Berk, L.; Laymon, M. 2014: Differences in anterior cruciate ligament elasticity and force for knee flexion in women: oral contraceptive users versus non-oral contraceptive users European Journal of Applied Physiology 114(2): 285-294